Pieper Steven has filed 29 insider transactions across 1 company since January 2022.
Most recent transaction: a option exercise of 27891 shares of Xeris Biopharma Holdings, Inc. ($XERS) on March 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | M | Stock Option (Right to Buy) | 27891 | $0.00 | 0.0000 | 177,617,307 | 100.00% | 0.02% |
| March 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | M | Common Stock | 14036 | $5.93 | 1,408,940.0000 | 177,617,307 | 1.01% | 0.01% |
| March 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | M | Common Stock | 27891 | $4.09 | 1,394,904.0000 | 177,617,307 | 2.04% | 0.02% |
| March 5, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | M | Stock Option (Right to Buy) | 14036 | $0.00 | 0.0000 | 177,617,307 | 100.00% | 0.01% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 27319 | $7.36 | 1,367,013.0000 | 177,617,307 | 1.96% | 0.02% |
| Jan. 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | A | Stock Option (Right to Buy) | 207207 | $0.00 | 207,207.0000 | 177,617,307 | 9999.99% | 0.12% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 66450 | $7.36 | 1,394,332.0000 | 177,617,307 | 4.55% | 0.04% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 111765 | $7.36 | 1,460,782.0000 | 177,617,307 | 7.11% | 0.06% |
| Jan. 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | A | Common Stock | 154986 | $0.00 | 1,572,547.0000 | 177,617,307 | 10.93% | 0.09% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 110750 | $3.56 | 1,299,011.0000 | 146,772,758 | 7.86% | 0.08% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 66450 | $3.56 | 1,232,561.0000 | 146,772,758 | 5.12% | 0.05% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | A | Common Stock | 185000 | $0.00 | 1,417,561.0000 | 146,772,758 | 15.01% | 0.13% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | A | Stock Appreciation Right | 300000 | $0.00 | 300,000.0000 | 146,772,758 | 9999.99% | 0.20% |
| Jan. 3, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 32059 | $3.61 | 1,409,761.0000 | 146,772,758 | 2.22% | 0.02% |
| Nov. 22, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | M | Stock Option (Right to Buy) | 2640 | $0.00 | 0.0000 | 148,993,823 | 100.00% | 0.00% |
| Nov. 22, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | M | Stock Option (Right to Buy) | 16843 | $0.00 | 0.0000 | 148,993,823 | 100.00% | 0.01% |
| Nov. 22, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | M | Common Stock | 19483 | $1.55 | 1,441,820.0000 | 148,993,823 | 1.37% | 0.01% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 110750 | $2.46 | 1,437,104.0000 | 137,674,857 | 7.16% | 0.08% |
| July 28, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 14767 | $2.61 | 1,422,337.0000 | 137,674,857 | 1.03% | 0.01% |
| Jan. 29, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 3590 | $1.26 | 1,586,278.0000 | 135,628,721 | 0.23% | 0.00% |
| Jan. 31, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 778 | $1.24 | 1,585,500.0000 | 135,628,721 | 0.05% | 0.00% |
| July 28, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 9767 | $1.43 | 1,612,935.0000 | 0 | 0.60% | 0.00% |
| Jan. 31, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 750 | $2.11 | 1,622,702.0000 | 0 | 0.05% | 0.00% |
| Jan. 29, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 3460 | $2.11 | 1,623,452.0000 | 0 | 0.21% | 0.00% |
| Jan. 3, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 23067 | $1.12 | 1,589,868.0000 | 135,628,721 | 1.43% | 0.02% |
| July 28, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 10200 | $2.53 | 1,575,300.0000 | 135,628,721 | 0.64% | 0.01% |
| Jan. 3, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 23067 | $2.24 | 1,552,233.0000 | 137,674,857 | 1.46% | 0.02% |
| Jan. 29, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | F | Common Stock | 4379 | $2.66 | 1,547,854.0000 | 137,674,857 | 0.28% | 0.00% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Pieper Steven | See Remarks | A | Common Stock | 450000 | $0.00 | 1,626,912.0000 | 137,674,857 | 38.24% | 0.33% |